Sort
50,496 grants matching “lung cancer”
Liver kinase B1 in angiogenesis
$460,084Ming-Hui Zou · Georgia State University · R01 · FY2020 · CA
Urokinase-type plasminogen activator (uPA) in pathogenesis of lymphangioleiomyomatosis (LAM)
$460,081Victoria Stepanova · University Of Pennsylvania · R01 · FY2021 · HL
Interpretable graphical models for large multi-modal COPD data (R01HL159805)
$460,061Panagiotis V Benos · University Of Florida · R01 · FY2024 · HL
Design, Synthesis, and Evaluation of Lactate Dehydrogenase Inhibitors
$460,019Paul Hergenrother · University Of Illinois At Urbana-Champaign · R01 · FY2012 · GM
RAND-UCLA CanCORS PDCR Application
$460,000Katherine L Kahn · Rand Corporation · U01 · FY2007 · CA
Detection of Chromosomal Translocations by Single Molecule RNA Imaging
$459,981Mona Batish · Rbhs-New Jersey Medical School · DP5 · FY2014 · OD
Detection of Chromosomal Translocations by Single Molecule RNA Imaging
$459,981Mona Batish · Rbhs-New Jersey Medical School · DP5 · FY2015 · OD
Opposing Functions of BRD4 Isoforms in Breast Cancer
$459,939Cheng-Ming Chiang · Ut Southwestern Medical Center · R01 · FY2021 · CA
Biologic Specimen Bank for Early Lung Cancer Markers
$459,909Christian Abnet · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
The Early Detection Research Network: Biomarker Referen*
$459,897David S Chia · University Of California Los Angeles · U24 · FY2009 · CA
A Fragment-Based Strategy for K-RAS Covalent Inhibitors
$459,832Samy Meroueh · Indiana University Indianapolis · R01 · FY2023 · CA
A Fragment-Based Strategy for K-RAS Covalent Inhibitors
$459,832Samy Meroueh · Indiana University Indianapolis · R01 · FY2022 · CA
Exploring Collateral Lethality for Development of Cancer Therapeutics
$459,831Ronald Anthony Depinho · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Project 1: Biomarkers Of Exposure Versus Effect: Improving The Scientific Basis F
$459,828James A Swenberg · Univ Of North Carolina Chapel Hill · P42 · FY2012 · ES
Core - Biomarker Development Laboratory (BDL)
$459,827James G. Herman · University Of Pittsburgh At Pittsburgh · U2C · FY2023 · CA
SCH: INT: Harnessing the Power of Technology: MOMBA for Postpartum Smoking
$459,820Megan Veenema Smith · Yale University · R01 · FY2015 · CA
Targeting macrophages in metastatic cancer
$459,802Anthony Rongvaux · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
The UGT2A and 3A metabolizing enzymes and tobacco-related cancer risk
$459,733Philip Lazarus · Washington State University · R01 · FY2016 · ES
The UGT2A and 3A metabolizing enzymes and tobacco-related cancer risk
$459,733Philip Lazarus · Washington State University · R01 · FY2015 · ES
Intervention Trials in Persons at Increased Genetic Risk of Cancer
$459,731Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA
PI3K Beta regulation of tumor metastasis
$459,711Anne R Bresnick · Albert Einstein College Of Medicine · P01 · FY2023 · CA
Developing knowledge models to enable rapid learning in radiation therapy
$459,607Qingrong Jackie Wu · Duke University · R01 · FY2016 · CA
Precise Correspondence of 3D Pathology with Radiological Features in Lung Nodules
$459,532Geoffrey McLennan · University Of Iowa · R01 · FY2007 · CA
Mutant Surfactant - Induced TGF-beta Secretion in Lung Fibrosis
$459,473Christine Kim Garcia · Ut Southwestern Medical Center · R01 · FY2017 · HL
Mutant Surfactant - Induced TGF-beta Secretion in Lung Fibrosis
$459,473Christine Kim Garcia · Ut Southwestern Medical Center · R01 · FY2016 · HL